Navigation Links
Informed Medical Communications Highlights Opportunity in Revised PhRMA Code
Date:8/11/2008

EDISON, N.J., Aug. 11 /PRNewswire/ -- Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, issued its position today on recent revisions to the PhRMA Code. "IMC remains fully committed to compliance with the PhRMA Code," noted Dr. Jaime Nguyen, Medical Director/Compliance Officer for IMC. "Though the guidelines have changed, we have continually monitored the compliance trends so that our services can remain a valuable resource for our clients in reaching their customers."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080512/NYM105LOGO )

With the ongoing restrictions on sales representative involvement, IMC (including The Peer Group and RxDialogue) has always proactively evolved its services to maintain the highest level of compliance rigor, enabling their clients a safe option for effectively meeting the needs of their brands. "IMC's medical communications will continue to be one of the few available tactics offering high-impact results for brand teams because its informational presentations and interactive discussions improve patient care and increase exposure to disease states and therapeutic choices," noted Kathleen Bresette, President of The Peer Group. Additionally, IMC's unique use of compliance-trained clinical Moderators ensures a viable, valuable method for supporting biopharmaceutical brands.

Steve Budd, CEO of IMC commented, "Because of this changing regulatory environment, IMC continually scrutinizes the compliance of its services, imbuing in our clients a confidence that IMC medical communications services like our Moderator Advantage Programs (MAPs) and teleconferences will remain an ideal tactic for discussing promotional on-label brand messages with healthcare professionals."

About Informed Medical Communications

Informed Medical Communications (http://www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting general and specialty peer-to-peer medical programs, respectively. Additionally, IMC's major businesses are enhanced by MRxHealth, the market research and consulting infrastructure that supports IMC's ongoing development and effectiveness of non-traditional marketing programs for biopharmaceutical clients, and Dialogue Training, a communications training service for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.


'/>"/>
SOURCE Informed Medical Communications
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedixs Med-eXpert(TM) System
2. Informed Medical Communications Adopts Newly Enhanced Compliance Policy
3. Informed Medical Communications Appoints New Chief Financial Officer
4. Informed Medical Communications Hires New Vice President of Marketing
5. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
6. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
7. ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies
8. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
9. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
11. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced ... FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)... Fla. , Dec. 8, 2016  HedgePath ... company that discovers, develops and plans to commercialize ... its shares of common stock were approved for ... will begin trading on the OTCQX, effective today, ... qualify for the OTCQX market, companies must meet ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
Breaking Biology Technology:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint ... ... Multi-Biometric supplier: The company's Fingerprint Identification System is part of an efficient ...
(Date:11/21/2016)... VILNIUS, Lithuania , Nov. 21, 2016 /PRNewswire/ ... identification and object recognition technologies, today announced that ... for smart cards was submitted for the ... and successfully passed all the mandatory steps of ... III evaluation is a continuing test of fingerprint ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
Breaking Biology News(10 mins):